Warsaw/Monaco, 5 August 2025

Carlson Investments SE announces that its healthtech portfolio company, Nutrix AG, is progressing toward the launch of cortiSense, a non-invasive, lab-grade cortisol monitoring sensor. The device recently won the CES Innovation Award 2025 in the Digital Health category, marking a new milestone in at-home hormone testing. Integrated with Nutrix’s gSense healthcare platform, cortiSense is designed to provide users with real-time hormonal data to support preventive health and chronic disease management.

Use of Proceeds and Development Plans
With the support of Carlson Investments SE and other strategic investors, Nutrix AG has raised USD 4 million to date. The company is advancing the commercialization of cortiSense and expanding its presence in international markets. Nutrix currently holds operational presence in Switzerland, Poland, Chile, Mexico, and Peru, with plans for further expansion into the U.S. and Japanese markets.

Current development efforts are focused on:
Scaling production capabilities for cortiSense to prepare for market introduction;
Integrating cortiSense with the gSense platform to combine hormonal data with glucose, diet, and body composition information;
Continuing research into the role of cortisol in metabolic, mental, and women’s health.


About Nutrix AG
Nutrix AG is a Swiss healthcare company developing AI-based solutions for non-invasive health monitoring. Originally focused on glucose detection in saliva to support diabetes management, Nutrix aims to help users prevent and manage chronic conditions through accessible, painless tracking methods.

About Carlson Investments SE
Carlson Investments SE, listed on Warsaw’s NewConnect and the German Open Market (Frankfurt, Munich, Stuttgart, Gettex), supports high-growth early-stage tech ventures across healthtech, AI, fintech, and deeptech. Carlson applies a hands-on investment approach and integrates its portfolio companies into a global network of strategic partnerships.

Risk Disclaimer
This announcement • does not constitute investment advice or a solicitation to buy or sell financial instruments • involves risks, including possible loss of capital • does not guarantee future earnings • past performance is not indicative of future results.

WE ARE PUBLICLY LISTED, YOU CAN BUY OUR SHARES ON:
Warsaw Stock Exchange (PLN): CAI, PLHOTB000011
Frankfurt Stock Exchange (EUR): 2HB (FRA), PLHOTB000011
Munich Stock Exchange (EUR): 2HB (MUN), PLHOTB000011
Stuttgart Stock Exchange (EUR): 2HB (STU), PLHOTB000011
GETTEX Exchange (EUR): 2HB (GET), PLHOTB000011
WKN: A0RNWQ

Press Contact:
Management Office
Carlson Investments SE
[email protected]